155 related articles for article (PubMed ID: 8528577)
1. Characterization of the effect of SR48692 on inositol monophosphate, cyclic GMP and cyclic AMP responses linked to neurotensin receptor activation in neuronal and non-neuronal cells.
Oury-Donat F; Thurneyssen O; Gonalons N; Forgez P; Gully D; Le Fur G; Soubrie P
Br J Pharmacol; 1995 Sep; 116(2):1899-905. PubMed ID: 8528577
[TBL] [Abstract][Full Text] [Related]
2. Neurotensin-mediated inhibition of cyclic AMP formation in neuroblastoma N1E115 cells: involvement of the inhibitory GTP-binding component of adenylate cyclase.
Bozou JC; Amar S; Vincent JP; Kitabgi P
Mol Pharmacol; 1986 May; 29(5):489-96. PubMed ID: 3010077
[TBL] [Abstract][Full Text] [Related]
3. Stimulation of inositol phosphate production by neurotensin in neuroblastoma N1E115 cells: implication of GTP-binding proteins and relationship with the cyclic GMP response.
Amar S; Kitabgi P; Vincent JP
J Neurochem; 1987 Oct; 49(4):999-1006. PubMed ID: 3040912
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of neurotensin-induced pancreatic carcinoma growth by a nonpeptide neurotensin receptor antagonist, SR48692.
Iwase K; Evers BM; Hellmich MR; Kim HJ; Higashide S; Gully D; Thompson JC; Townsend CM
Cancer; 1997 May; 79(9):1787-93. PubMed ID: 9128997
[TBL] [Abstract][Full Text] [Related]
5. The non-peptide neurotensin receptor antagonist SR48692 is not a potent antagonist of neurotensin(8-13) responses of rat substantia nigra neurones in vitro.
Pinnock RD; Woodruff GN
Neurosci Lett; 1994 May; 172(1-2):175-8. PubMed ID: 8084529
[TBL] [Abstract][Full Text] [Related]
6. Regulation of cyclic GMP levels by neurotensin in neuroblastoma clone N1E115.
Amar S; Mazella J; Checler F; Kitabgi P; Vincent JP
Biochem Biophys Res Commun; 1985 May; 129(1):117-25. PubMed ID: 2988544
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the stimulation of inositol phospholipid hydrolysis and of cyclic GMP formation by neurotensin, some of its analogs, and neuromedin N in neuroblastoma clone N1E-115.
Kanba KS; Richelson E
Biochem Pharmacol; 1987 Mar; 36(6):869-74. PubMed ID: 3032199
[TBL] [Abstract][Full Text] [Related]
8. Electrophysiological evidence for putative subtypes of neurotensin receptors in guinea-pig mesencephalic dopaminergic neurons.
Nalivaiko E; Michaud JC; Soubrié P; Le Fur G
Neuroscience; 1998 Oct; 86(3):799-811. PubMed ID: 9692718
[TBL] [Abstract][Full Text] [Related]
9. In vitro functional evidence of different neurotensin-receptors modulating the motor response of human colonic muscle strips.
Croci T; Aureggi G; Guagnini F; Manara L; Gully D; Fur GL; Maffrand JP; Mukenge S; Ferla G; Ferrara P; Chalon P; Vita N
Br J Pharmacol; 1999 Aug; 127(8):1922-8. PubMed ID: 10482925
[TBL] [Abstract][Full Text] [Related]
10. Neurotensin stimulates inositol phospholipid metabolism and calcium mobilization in murine neuroblastoma clone N1E-115.
Snider RM; Forray C; Pfenning M; Richelson E
J Neurochem; 1986 Oct; 47(4):1214-8. PubMed ID: 3018165
[TBL] [Abstract][Full Text] [Related]
11. Activation of phosphatidylinositol turnover by neurotensin receptors in the human colonic adenocarcinoma cell line HT29.
Amar S; Kitabgi P; Vincent JP
FEBS Lett; 1986 May; 201(1):31-6. PubMed ID: 3011505
[TBL] [Abstract][Full Text] [Related]
12. SR142948A is a potent antagonist of the cardiovascular effects of neurotensin.
Schaeffer P; Laplace MC; Bernat A; Prabonnaud V; Gully D; Lespy L; Herbert JM
J Cardiovasc Pharmacol; 1998 Apr; 31(4):545-50. PubMed ID: 9554803
[TBL] [Abstract][Full Text] [Related]
13. SR48692 is a neurotensin receptor antagonist which inhibits the growth of small cell lung cancer cells.
Moody TW; Chiles J; Casibang M; Moody E; Chan D; Davis TP
Peptides; 2001 Jan; 22(1):109-15. PubMed ID: 11179604
[TBL] [Abstract][Full Text] [Related]
14. Pretreatment with SR48692 has different effects on central neurotensin-induced gastric mucosal defense and inhibition of gastric acid secretion in rats.
Karinch AM; Schmidt GL; Kauffman GL
Brain Res; 1998 Nov; 810(1-2):123-9. PubMed ID: 9813278
[TBL] [Abstract][Full Text] [Related]
15. Biochemical and pharmacological profile of a potent and selective nonpeptide antagonist of the neurotensin receptor.
Gully D; Canton M; Boigegrain R; Jeanjean F; Molimard JC; Poncelet M; Gueudet C; Heaulme M; Leyris R; Brouard A
Proc Natl Acad Sci U S A; 1993 Jan; 90(1):65-9. PubMed ID: 8380498
[TBL] [Abstract][Full Text] [Related]
16. Desensitization of neurotensin receptor-mediated cyclic GMP formation in neuroblastoma clone N1E-115.
Gilbert JA; Strobel TR; Richelson E
Biochem Pharmacol; 1988 Jul; 37(14):2833-8. PubMed ID: 2840079
[TBL] [Abstract][Full Text] [Related]
17. Distinct functional characteristics of levocabastine sensitive rat neurotensin NT2 receptor expressed in Chinese hamster ovary cells.
Yamada M; Yamada M; Lombet A; Forgez P; Rostène W
Life Sci; 1998; 62(23):PL 375-80. PubMed ID: 9627096
[TBL] [Abstract][Full Text] [Related]
18. Indirect inhibitory effect of a neurotensin receptor antagonist on human colon cancer (LoVo) growth.
Iwase K; Evers BM; Hellmich MR; Kim HJ; Higashide S; Gully D; Townsend CM
Surg Oncol; 1996; 5(5-6):245-51. PubMed ID: 9129137
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of the nonpeptide neurotensin antagonist, SR 48692, on the pharmacological effects of neurotensin agonists.
Pugsley TA; Akunne HC; Whetzel SZ; Demattos S; Corbin AE; Wiley JN; Wustrow DJ; Wise LD; Heffner TG
Peptides; 1995; 16(1):37-44. PubMed ID: 7716073
[TBL] [Abstract][Full Text] [Related]
20. Effects of clozapine on rat striatal muscarinic receptors coupled to inhibition of adenylyl cyclase activity and on the human cloned m4 receptor.
Olianas MC; Maullu C; Onali P
Br J Pharmacol; 1997 Oct; 122(3):401-8. PubMed ID: 9351494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
